Literature DB >> 27026435

Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases.

Kojiro Hyodo1, Tomofumi Nishino2, Hiroshi Kamada2, Daisuke Nozawa2, Hajime Mishima2, Masashi Yamazaki2.   

Abstract

The purpose of this study was to determine fracture location and the characteristics of patients with atypical femoral fractures (AFFs). We studied 38 AFFs in 34 patients admitted to our institution between November 2007 and July 2013. The diagnostic criteria for the AFFs were based on 2014 American Society of Bone and Mineral Research guidelines. We classified the fracture location as proximal, middle, or distal to trisect the femoral diaphysis from just distal to the lesser trochanter to just proximal to the supracondylar flare. Bowing was defined as a line through the inside of the tip of the great trochanter and a condylar center that was outside the medullary cavity. We investigated the fracture's location, existence of coronal bowing, and bisphosphonates (BPs), glucocorticoids (GCs), and proton pump inhibitors therapy. We analyzed associations between fracture location and demographic and clinical factors. Twelve fractures were proximal, 25 were middle, and one was distal. Nineteen limbs showed femoral bowing. Thirty-one patients received BP treatment-20 patients received alendronic acid, eight risedronic acid, and three minodronic acid. Fourteen patients received a GC, and 16 received a proton pump inhibitor. There was a significant association between coronal bowing and middle fracture locations, GC therapy and proximal fracture locations, and older age and middle fracture locations. Tall height and heavy weight had an association with proximal fracture location, and short height and light weight had an association with middle fracture location. In conclusion, we provide evidence supporting a causal relationship between BP-related severely suppressed bone turnover and AFFs. We also provide evidence supporting additional influences from altered distribution of mechanical stress with femoral bowing and various factors, such as GC therapy, age, body weight, and height, which might negatively affect bone intensity and quality and result in fracture.

Entities:  

Keywords:  Atypical femoral fracture; Bisphosphonate treatment; Bowing; Fracture location; Glucocorticoid

Mesh:

Substances:

Year:  2016        PMID: 27026435     DOI: 10.1007/s00774-016-0747-x

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  12 in total

1.  The incidence of and risk factors for developing atypical femoral fractures in Japan.

Authors:  Yoshitomo Saita; Muneaki Ishijima; Atsuhiko Mogami; Mitsuaki Kubota; Tomonori Baba; Takefumi Kaketa; Masashi Nagao; Yuko Sakamoto; Kensuke Sakai; Yasuhiro Homma; Rui Kato; Nana Nagura; Kei Miyagawa; Tomoki Wada; Lizu Liu; Joe Matsuoka; Osamu Obayashi; Katsuo Shitoto; Masahiko Nozawa; Hajime Kajihara; Hogaku Gen; Kazuo Kaneko
Journal:  J Bone Miner Metab       Date:  2014-05-23       Impact factor: 2.626

2.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

3.  Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Authors:  Andrea Giusti; Neveen A T Hamdy; Olaf M Dekkers; Sharita R Ramautar; Sander Dijkstra; Socrates E Papapoulos
Journal:  Bone       Date:  2010-12-31       Impact factor: 4.398

4.  Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study.

Authors:  D Chappard; E Legrand; M F Basle; P Fromont; J L Racineux; A Rebel; M Audran
Journal:  J Bone Miner Res       Date:  1996-05       Impact factor: 6.741

5.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

6.  The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment.

Authors:  Yoshitomo Saita; Muneaki Ishijima; Atsuhiko Mogami; Mitsuaki Kubota; Tomonori Baba; Takefumi Kaketa; Masashi Nagao; Yuko Sakamoto; Kensuke Sakai; Rui Kato; Nana Nagura; Kei Miyagawa; Tomoki Wada; Lizu Liu; Osamu Obayashi; Katsuo Shitoto; Masahiko Nozawa; Hajime Kajihara; Hogaku Gen; Kazuo Kaneko
Journal:  Bone       Date:  2014-06-14       Impact factor: 4.398

Review 7.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

Review 8.  Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.

Authors:  R N J De Nijs
Journal:  Minerva Med       Date:  2008-02       Impact factor: 4.806

9.  Low-energy femoral shaft fractures associated with alendronate use.

Authors:  Andrew S Neviaser; Joseph M Lane; Brett A Lenart; Folorunsho Edobor-Osula; Dean G Lorich
Journal:  J Orthop Trauma       Date:  2008 May-Jun       Impact factor: 2.512

10.  Histology of 8 atypical femoral fractures: remodeling but no healing.

Authors:  Jörg Schilcher; Olof Sandberg; Hanna Isaksson; Per Aspenberg
Journal:  Acta Orthop       Date:  2014-04-30       Impact factor: 3.717

View more
  13 in total

1.  High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; T Nakatsue; Y Wada; J Fujisawa; J J Kazama; T Kuroda; Y Suzuki; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

2.  Surgical results of atypical femoral fractures in long-term bisphosphonate and glucocorticoid users - Relationship between fracture reduction and bone union.

Authors:  Tomofumi Nishino; Kojiro Hyodo; Yukei Matsumoto; Yohei Yanagisawa; Tomohiro Yoshizawa; Masashi Yamazaki
Journal:  J Orthop       Date:  2019-11-27

Review 3.  The Role of Lower-Limb Geometry in the Pathophysiology of Atypical Femoral Fracture.

Authors:  Ifaz T Haider; Prism S Schneider; W Brent Edwards
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

4.  Post-operative Rehabilitation of Atypical Femoral Fracture in a Single Center.

Authors:  Yasuhiko Mizutani; Hiroshi Horiuchi; Yoshiyuki Nakamura; Masataka Mochizuki; Yoshiyuki Kotoda; Tsuyoshi Toyata; Taketomo Ozaki; Tsutomu Takizawa
Journal:  Prog Rehabil Med       Date:  2020-04-14

5.  Lower trabecular bone score is associated with an increased incidence of localized femoral periosteal thickening.

Authors:  Hiroe Sato; Naoki Kondo; Yoichi Kurosawa; Eriko Hasegawa; Ayako Wakamatsu; Daisuke Kobayashi; Takeshi Nakatsue; Junichiro James Kazama; Takeshi Kuroda; Yoshiki Suzuki; Naoto Endo; Ichiei Narita
Journal:  J Bone Miner Metab       Date:  2021-07-20       Impact factor: 2.626

6.  Atypical Femoral Shaft Fractures in Female Bisphosphonate Users Were Associated with an Increased Anterolateral Femoral Bow and a Thicker Lateral Cortex: A Case-Control Study.

Authors:  Seung Pil Jang; Ingwon Yeo; Sang-Yeon So; Keunbyuel Kim; Young-Wan Moon; Youn-Soo Park; Seung-Jae Lim
Journal:  Biomed Res Int       Date:  2017-03-28       Impact factor: 3.411

7.  Localization of Atypical Femoral Fracture on Straight and Bowed Femurs.

Authors:  Young-Chang Park; Soon-Phil Yoon; Kyu Hyun Yang
Journal:  J Bone Metab       Date:  2019-05-31

8.  The Influence of Demographic Factors on the Location of Bisphosphonate-related Atypical Femoral Fractures.

Authors:  Wei Yuan; Ernest B K Kwek
Journal:  Indian J Orthop       Date:  2020-07-28       Impact factor: 1.251

9.  The enigma of atypical femoral fractures: A summary of current knowledge.

Authors:  Morten Schultz Larsen; Hagen Schmal
Journal:  EFORT Open Rev       Date:  2018-09-12

10.  Atypical periprosthetic femoral fractures after arthroplasty for fracture are at high risk of complications.

Authors:  Tomonori Baba; Masataka Uchino; Hironori Ochi; Takuya Ikuta; Yoshitomo Saita; Hiroshi Hagino; Hiroaki Nonomiya; Seiya Jingushi; Takayuki Nakajima; Yasuhisa Ueda; Kaneko Kazuo
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.